APO Research
Talk to an analyst

APO RESEARCH · REPORT

Celiac Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Celiac Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchCeliac Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Celiac Drugs Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Celiac Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Celiac Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Celiac Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Celiac Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Celiac Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Celiac Drugs include Johnson & Johnson, Novartis, Merck, Biogen, Bayer, Amgen, LFB Group, Kedrion Biopharma and Innovate Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Celiac Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Celiac Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Celiac Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Celiac Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Celiac Drugs Segment by Company

Johnson & Johnson

Novartis

Merck

Biogen

Bayer

Amgen

LFB Group

Kedrion Biopharma

Innovate Biopharmaceuticals

ImmusanT

Immunomedics

ImmunogenX

F Hoffmann-La Roche

Celimmune

Celgene

Bristol-Myers Squibb

Biotest

BioLineRx

Anthera Pharmaceuticals

ADMA Biologics

Celiac Drugs Segment by Type

First Line Of Treatment

Second Line Of Treatment

Celiac Drugs Segment by Application

Women

Men

Children

Celiac Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celiac Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Celiac Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celiac Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Celiac Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Celiac Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Celiac Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Celiac Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Celiac Drugs Industry Trends Table 2. Celiac Drugs Industry Drivers Table 3. Celiac Drugs Industry Opportunities and Challenges Table 4. Celiac Drugs Industry Restraints Table 5. Global Celiac Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Celiac Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Celiac Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Celiac Drugs Sales Market Share by Manufacturers Table 9. Global Celiac Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Celiac Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Celiac Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Celiac Drugs Manufacturers, Product Type & Application Table 13. Global Celiac Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Celiac Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of First Line Of Treatment Table 17. Major Manufacturers of Second Line Of Treatment Table 18. Global Celiac Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Celiac Drugs Sales by Type (2021-2026) & (k units) Table 20. Global Celiac Drugs Sales by Type (2027-2032) & (k units) Table 21. Global Celiac Drugs Sales Market Share by Type (2021-2026) Table 22. Global Celiac Drugs Sales Market Share by Type (2027-2032) Table 23. Global Celiac Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Celiac Drugs Revenue by Type (2021-2026) & (k units) Table 25. Global Celiac Drugs Revenue by Type (2027-2032) & (k units) Table 26. Global Celiac Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Celiac Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Women Table 29. Major Manufacturers of Men Table 30. Major Manufacturers of Children Table 31. Global Celiac Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Celiac Drugs Sales by Application (2021-2026) & (k units) Table 33. Global Celiac Drugs Sales by Application (2027-2032) & (k units) Table 34. Global Celiac Drugs Sales Market Share by Application (2021-2026) Table 35. Global Celiac Drugs Sales Market Share by Application (2027-2032) Table 36. Global Celiac Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Celiac Drugs Revenue by Application (2021-2026) & (k units) Table 38. Global Celiac Drugs Revenue by Application (2027-2032) & (k units) Table 39. Global Celiac Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Celiac Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Celiac Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Celiac Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Celiac Drugs Sales Market Share by Region (2021-2026) Table 44. Global Celiac Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Celiac Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Celiac Drugs Sales by Country (2021-2026) & (k units) Table 48. North America Celiac Drugs Sales by Country (2027-2032) & (k units) Table 49. Europe Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Celiac Drugs Sales by Country (2021-2026) & (k units) Table 51. Europe Celiac Drugs Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Celiac Drugs Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Celiac Drugs Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Celiac Drugs Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Celiac Drugs Sales by Country (2027-2032) & (k units) Table 58. Global Celiac Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Celiac Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Celiac Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Celiac Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Celiac Drugs Revenue Market Share by Region (2027-2032) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Celiac Drugs Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Celiac Drugs Product Portfolio Table 72. Novartis Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Celiac Drugs Product Portfolio Table 77. Merck Recent Development Table 78. Biogen Company Information Table 79. Biogen Business Overview Table 80. Biogen Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Biogen Celiac Drugs Product Portfolio Table 82. Biogen Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bayer Celiac Drugs Product Portfolio Table 87. Bayer Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Amgen Celiac Drugs Product Portfolio Table 92. Amgen Recent Development Table 93. LFB Group Company Information Table 94. LFB Group Business Overview Table 95. LFB Group Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. LFB Group Celiac Drugs Product Portfolio Table 97. LFB Group Recent Development Table 98. Kedrion Biopharma Company Information Table 99. Kedrion Biopharma Business Overview Table 100. Kedrion Biopharma Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Kedrion Biopharma Celiac Drugs Product Portfolio Table 102. Kedrion Biopharma Recent Development Table 103. Innovate Biopharmaceuticals Company Information Table 104. Innovate Biopharmaceuticals Business Overview Table 105. Innovate Biopharmaceuticals Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Innovate Biopharmaceuticals Celiac Drugs Product Portfolio Table 107. Innovate Biopharmaceuticals Recent Development Table 108. ImmusanT Company Information Table 109. ImmusanT Business Overview Table 110. ImmusanT Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. ImmusanT Celiac Drugs Product Portfolio Table 112. ImmusanT Recent Development Table 113. Immunomedics Company Information Table 114. Immunomedics Business Overview Table 115. Immunomedics Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Immunomedics Celiac Drugs Product Portfolio Table 117. Immunomedics Recent Development Table 118. ImmunogenX Company Information Table 119. ImmunogenX Business Overview Table 120. ImmunogenX Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. ImmunogenX Celiac Drugs Product Portfolio Table 122. ImmunogenX Recent Development Table 123. F Hoffmann-La Roche Company Information Table 124. F Hoffmann-La Roche Business Overview Table 125. F Hoffmann-La Roche Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. F Hoffmann-La Roche Celiac Drugs Product Portfolio Table 127. F Hoffmann-La Roche Recent Development Table 128. Celimmune Company Information Table 129. Celimmune Business Overview Table 130. Celimmune Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Celimmune Celiac Drugs Product Portfolio Table 132. Celimmune Recent Development Table 133. Celgene Company Information Table 134. Celgene Business Overview Table 135. Celgene Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Celgene Celiac Drugs Product Portfolio Table 137. Celgene Recent Development Table 138. Bristol-Myers Squibb Company Information Table 139. Bristol-Myers Squibb Business Overview Table 140. Bristol-Myers Squibb Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Bristol-Myers Squibb Celiac Drugs Product Portfolio Table 142. Bristol-Myers Squibb Recent Development Table 143. Biotest Company Information Table 144. Biotest Business Overview Table 145. Biotest Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Biotest Celiac Drugs Product Portfolio Table 147. Biotest Recent Development Table 148. BioLineRx Company Information Table 149. BioLineRx Business Overview Table 150. BioLineRx Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. BioLineRx Celiac Drugs Product Portfolio Table 152. BioLineRx Recent Development Table 153. Anthera Pharmaceuticals Company Information Table 154. Anthera Pharmaceuticals Business Overview Table 155. Anthera Pharmaceuticals Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Anthera Pharmaceuticals Celiac Drugs Product Portfolio Table 157. Anthera Pharmaceuticals Recent Development Table 158. ADMA Biologics Company Information Table 159. ADMA Biologics Business Overview Table 160. ADMA Biologics Celiac Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. ADMA Biologics Celiac Drugs Product Portfolio Table 162. ADMA Biologics Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Celiac Drugs Distributors List Table 166. Celiac Drugs Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Celiac Drugs Product Image Figure 2. Global Celiac Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Celiac Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Celiac Drugs Sales (2021-2032) & (k units) Figure 5. Global Celiac Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Celiac Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. First Line Of Treatment Image Figure 9. Second Line Of Treatment Image Figure 10. Global Celiac Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Celiac Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Celiac Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Celiac Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Celiac Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Celiac Drugs Revenue Market Share by Type (2021-2032) Figure 16. Women Image Figure 17. Men Image Figure 18. Children Image Figure 19. Global Celiac Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Celiac Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Celiac Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Celiac Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Celiac Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Celiac Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Celiac Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Celiac Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Celiac Drugs Sales Market Share by Country (2021-2032) Figure 39. China Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Celiac Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Celiac Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Celiac Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Celiac Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Celiac Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Celiac Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Celiac Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Celiac Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Celiac Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Celiac Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • First Line Of Treatment
  • Second Line Of Treatment
Applications
  • Women
  • Men
  • Children
Companies covered
  • Johnson & Johnson
  • Novartis
  • Merck
  • Biogen
  • Bayer
  • Amgen
  • LFB Group
  • Kedrion Biopharma
  • Innovate Biopharmaceuticals
  • ImmusanT
  • Immunomedics
  • ImmunogenX
  • F Hoffmann-La Roche
  • Celimmune
  • Celgene
  • Bristol-Myers Squibb
  • Biotest
  • BioLineRx
  • Anthera Pharmaceuticals
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Celiac Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Celiac Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Celiac Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Celiac Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Celiac Drugs Market Dynamics
  1. 2.1 Celiac Drugs Industry Trends
  2. 2.2 Celiac Drugs Industry Drivers
  3. 2.3 Celiac Drugs Industry Opportunities and Challenges
  4. 2.4 Celiac Drugs Industry Restraints
3 Celiac Drugs Market by Manufacturers
  1. 3.1 Global Celiac Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Celiac Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Celiac Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Celiac Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Celiac Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Celiac Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Celiac Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Celiac Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Celiac Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Celiac Drugs Tier 1, Tier 2, and Tier 3
4 Celiac Drugs Market by Type
  1. 4.1 Celiac Drugs Type Introduction
  2. 4.1.1 First Line Of Treatment
  3. 4.1.2 Second Line Of Treatment
  4. 4.2 Global Celiac Drugs Sales by Type
  5. 4.2.1 Global Celiac Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Celiac Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Celiac Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Celiac Drugs Revenue by Type
  9. 4.3.1 Global Celiac Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Celiac Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Celiac Drugs Revenue Market Share by Type (2021-2032)
5 Celiac Drugs Market by Application
  1. 5.1 Celiac Drugs Application Introduction
  2. 5.1.1 Women
  3. 5.1.2 Men
  4. 5.1.3 Children
  5. 5.2 Global Celiac Drugs Sales by Application
  6. 5.2.1 Global Celiac Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Celiac Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Celiac Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Celiac Drugs Revenue by Application
  10. 5.3.1 Global Celiac Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Celiac Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Celiac Drugs Revenue Market Share by Application (2021-2032)
6 Global Celiac Drugs Sales by Region
  1. 6.1 Global Celiac Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Celiac Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Celiac Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Celiac Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Celiac Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Celiac Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Celiac Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Celiac Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Celiac Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Celiac Drugs Revenue by Region
  1. 7.1 Global Celiac Drugs Revenue by Region
  2. 7.1.1 Global Celiac Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Celiac Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Celiac Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Celiac Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Celiac Drugs Revenue (2021-2032)
  8. 7.2.2 North America Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Celiac Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Celiac Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Celiac Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Celiac Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Celiac Drugs Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Celiac Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Celiac Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Biogen
  20. 8.4.1 Biogen Company Information
  21. 8.4.2 Biogen Business Overview
  22. 8.4.3 Biogen Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biogen Celiac Drugs Product Portfolio
  24. 8.4.5 Biogen Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Celiac Drugs Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 Amgen
  32. 8.6.1 Amgen Company Information
  33. 8.6.2 Amgen Business Overview
  34. 8.6.3 Amgen Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Amgen Celiac Drugs Product Portfolio
  36. 8.6.5 Amgen Recent Developments
  37. 8.7 LFB Group
  38. 8.7.1 LFB Group Company Information
  39. 8.7.2 LFB Group Business Overview
  40. 8.7.3 LFB Group Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LFB Group Celiac Drugs Product Portfolio
  42. 8.7.5 LFB Group Recent Developments
  43. 8.8 Kedrion Biopharma
  44. 8.8.1 Kedrion Biopharma Company Information
  45. 8.8.2 Kedrion Biopharma Business Overview
  46. 8.8.3 Kedrion Biopharma Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kedrion Biopharma Celiac Drugs Product Portfolio
  48. 8.8.5 Kedrion Biopharma Recent Developments
  49. 8.9 Innovate Biopharmaceuticals
  50. 8.9.1 Innovate Biopharmaceuticals Company Information
  51. 8.9.2 Innovate Biopharmaceuticals Business Overview
  52. 8.9.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Innovate Biopharmaceuticals Celiac Drugs Product Portfolio
  54. 8.9.5 Innovate Biopharmaceuticals Recent Developments
  55. 8.10 ImmusanT
  56. 8.10.1 ImmusanT Company Information
  57. 8.10.2 ImmusanT Business Overview
  58. 8.10.3 ImmusanT Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ImmusanT Celiac Drugs Product Portfolio
  60. 8.10.5 ImmusanT Recent Developments
  61. 8.11 Immunomedics
  62. 8.11.1 Immunomedics Company Information
  63. 8.11.2 Immunomedics Business Overview
  64. 8.11.3 Immunomedics Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Immunomedics Celiac Drugs Product Portfolio
  66. 8.11.5 Immunomedics Recent Developments
  67. 8.12 ImmunogenX
  68. 8.12.1 ImmunogenX Company Information
  69. 8.12.2 ImmunogenX Business Overview
  70. 8.12.3 ImmunogenX Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ImmunogenX Celiac Drugs Product Portfolio
  72. 8.12.5 ImmunogenX Recent Developments
  73. 8.13 F Hoffmann-La Roche
  74. 8.13.1 F Hoffmann-La Roche Company Information
  75. 8.13.2 F Hoffmann-La Roche Business Overview
  76. 8.13.3 F Hoffmann-La Roche Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 F Hoffmann-La Roche Celiac Drugs Product Portfolio
  78. 8.13.5 F Hoffmann-La Roche Recent Developments
  79. 8.14 Celimmune
  80. 8.14.1 Celimmune Company Information
  81. 8.14.2 Celimmune Business Overview
  82. 8.14.3 Celimmune Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Celimmune Celiac Drugs Product Portfolio
  84. 8.14.5 Celimmune Recent Developments
  85. 8.15 Celgene
  86. 8.15.1 Celgene Company Information
  87. 8.15.2 Celgene Business Overview
  88. 8.15.3 Celgene Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Celgene Celiac Drugs Product Portfolio
  90. 8.15.5 Celgene Recent Developments
  91. 8.16 Bristol-Myers Squibb
  92. 8.16.1 Bristol-Myers Squibb Company Information
  93. 8.16.2 Bristol-Myers Squibb Business Overview
  94. 8.16.3 Bristol-Myers Squibb Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bristol-Myers Squibb Celiac Drugs Product Portfolio
  96. 8.16.5 Bristol-Myers Squibb Recent Developments
  97. 8.17 Biotest
  98. 8.17.1 Biotest Company Information
  99. 8.17.2 Biotest Business Overview
  100. 8.17.3 Biotest Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biotest Celiac Drugs Product Portfolio
  102. 8.17.5 Biotest Recent Developments
  103. 8.18 BioLineRx
  104. 8.18.1 BioLineRx Company Information
  105. 8.18.2 BioLineRx Business Overview
  106. 8.18.3 BioLineRx Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BioLineRx Celiac Drugs Product Portfolio
  108. 8.18.5 BioLineRx Recent Developments
  109. 8.19 Anthera Pharmaceuticals
  110. 8.19.1 Anthera Pharmaceuticals Company Information
  111. 8.19.2 Anthera Pharmaceuticals Business Overview
  112. 8.19.3 Anthera Pharmaceuticals Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Anthera Pharmaceuticals Celiac Drugs Product Portfolio
  114. 8.19.5 Anthera Pharmaceuticals Recent Developments
  115. 8.20 ADMA Biologics
  116. 8.20.1 ADMA Biologics Company Information
  117. 8.20.2 ADMA Biologics Business Overview
  118. 8.20.3 ADMA Biologics Celiac Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 ADMA Biologics Celiac Drugs Product Portfolio
  120. 8.20.5 ADMA Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Celiac Drugs Value Chain Analysis
  2. 9.1.1 Celiac Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Celiac Drugs Production Mode & Process
  6. 9.2 Celiac Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Celiac Drugs Distributors
  9. 9.2.3 Celiac Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst